» Articles » PMID: 20439033

BCAN Think Tank Session 2: Molecular Detection of Bladder Cancer: the Path to Progress

Overview
Journal Urol Oncol
Publisher Elsevier
Date 2010 May 5
PMID 20439033
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Initial detection of bladder cancer and surveillance for cancer recurrence and progression are central topics in the field of urologic oncology. A session at the 3rd Annual Bladder Cancer Think Tank Meeting focused on urine-based markers for bladder cancer screening and surveillance. Here, we review the key points from the presentations, as well as the recommendations from a working group tasked with critically evaluating the information discussed in the session. Although the practicality of markers has been challenged, the resounding consensus was that continued research efforts directed at developing and evaluating markers for screening and early detection are warranted.

Citing Articles

Rationale for an early detection program for bladder cancer.

Khochikar M Indian J Urol. 2011; 27(2):218-25.

PMID: 21814313 PMC: 3142833. DOI: 10.4103/0970-1591.82841.


Metabolic profiling for the detection of bladder cancer.

Van Q, Veenstra T, Issaq H Curr Urol Rep. 2010; 12(1):34-40.

PMID: 21061098 DOI: 10.1007/s11934-010-0151-3.